MedTrace Logo

Multicenter Retrospective Study on Patients Treated with Stereotactic Radiosurgery/Radiotherapy for Single Brain Lesions: Evaluation of Treatment Efficacy and Safety, Also Through Radiomic Analysis Methods.

NCT06869460 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 372

Last updated 2025-03-11

No results posted yet for this study

Summary

The study design concerns all patients diagnosed witha singular brain metastasis who underwent stereotactic radiosurgery/radiotherapy between January 2010 and December 2022

Conditions

Interventions

RADIATION

Stereotactic Body Radiotherapy/Radiosurgery

Stereotactic Body Radiotherapy/Radiosurgery

Sponsors & Collaborators

  • Gemelli Molise Hospital

    lead OTHER

Principal Investigators

  • Donato Pezzulla, M.D. · Responsible Research Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-20
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06869460 on ClinicalTrials.gov